Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 17

1.

The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.

Yood MU, DeLorenze G, Quesenberry CP Jr, Oliveria SA, Tsai AL, Willey VJ, McQuade R, Newcomer J, L'Italien G.

Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):791-9. doi: 10.1002/pds.1781.

PMID:
19526626
2.

An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.

Krzystanek M, Krupka-Matuszczyk I.

Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Review.

PMID:
23055416
3.
4.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
5.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
6.

Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies.

Ramaswamy K, Masand PS, Nasrallah HA.

Ann Clin Psychiatry. 2006 Jul-Sep;18(3):183-94. Review.

PMID:
16923657
7.

Antipsychotics in pregnancy.

McCauley-Elsom K, Gurvich C, Elsom SJ, Kulkarni J.

J Psychiatr Ment Health Nurs. 2010 Mar;17(2):97-104. doi: 10.1111/j.1365-2850.2009.01481.x. Review.

PMID:
20465753
8.
9.

Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

McDougle CJ, Stigler KA, Erickson CA, Posey DJ.

J Clin Psychiatry. 2008;69 Suppl 4:15-20. Review.

PMID:
18533764
10.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
11.

The dosing of atypical antipsychotics.

de Leon J, Armstrong SC, Cozza KL.

Psychosomatics. 2005 May-Jun;46(3):262-73. Review.

PMID:
15883149
12.

Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials.

Bushe CJ, Leonard BE.

J Clin Psychiatry. 2007 Nov;68(11):1682-90. Review.

PMID:
18052561
13.

The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.

Citrome L, Volavka J.

Postgrad Med. 2004 Oct;116(4):49-51, 55-9, 63. Review.

PMID:
15510593
14.

Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.

Margolese HC, Chouinard G, Kolivakis TT, Beauclair L, Miller R, Annable L.

Can J Psychiatry. 2005 Oct;50(11):703-14. Review.

PMID:
16363464
15.

Hyperglycemia associated with the use of atypical antipsychotics.

Lindenmayer JP, Nathan AM, Smith RC.

J Clin Psychiatry. 2001;62 Suppl 23:30-8. Review.

PMID:
11603883
16.

Antipsychotic-induced weight gain: a comprehensive research synthesis.

Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ.

Am J Psychiatry. 1999 Nov;156(11):1686-96. Review.

PMID:
10553730
17.

The association between antipsychotic agents and the risk of myocardial infarction: a systematic review.

Brauer R, Douglas I, Smeeth L.

Br J Clin Pharmacol. 2011 Dec;72(6):871-8. doi: 10.1111/j.1365-2125.2011.04043.x. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk